text:
While businesses continue to bail on Paula Deen in light of the racial controversy that is damaging her reputation as the Queen of Southern Cooking, fans are showing that she is not alone in this fight.
Based on an earlier Forbes story published Thursday morning, PEOPLE reported Deen had been dropped from the Novo Nordisk deal that caused a stir last year when she announced that she had ben living with Type 2 diabetes for three years – but a spokesperson for the global healthcare company says that simply isn't true.
"It's too early to suggest what we will wind up doing but we have not dropped Paula Deen," the spokesperson said. "We just felt the recent controversy affected her ability to help manage and work towards our mission which is around changing diabetes. It's unclear what effect this controversy will have on users of the diabetes drug."
The spokesperson continued, "People need to focus on the fact that diabetes is a serious personal disease. They manage the disease on their own terms. I would never suggest people should make a decision about managing there disease based on an emotional decision. If a drug is helping them effectively manage their diabetes, then that should be their deciding factor and that should be a decision between them and their doctor."
Target also has decided to get out of the Deen business.
"We have made a decision to phase out the Paula Deen merchandise in our stores as well as on Target.com. Once the merchandise is sold out, we will not be replenishing inventory," the brand said in a statement on Thursday.
QVC has decided to "pause" their relationship with Deen. In a letter to customers on Thursday, President and CEO Mike George wrote, "We have talked with Paula and her team extensively over the last several days, and together we have considered what is best for our customers, for Paula, and for QVC. For now, we have decided to take a pause."
He continued, "Paula won't be appearing on any upcoming broadcasts and we will phase out her product assortment on our online sales channels over the next few months. We all think it's important, at this moment, for Paula to concentrate on responding to the allegations against her and on her path forward."
Deen also issued a letter to the televised shopping network's customers, writing, "As you know, I have some important things to work on right now, both personally and professionally. And so we've agreed that it's best for me to step back from QVC and focus on setting things right. I am truly sorry and assure you I will work hard to earn your forgiveness."
But Deen fans are showing their support online: Along with posting their ire on Food Network's Facebook page, Deen's upcoming cookbook Paula Deen's New Testament: 250 Favorite Recipes, All Lightened Up has shot to the No.1 spot on Amazon.com.
Additionally, tickets to the annual Paula Deen cruise have been so popular a second voyage has been added to the schedule for 2014.
"Due to so many requests from Paula's fans in the past we are actually planning two cruises for 2014 and look forward to both," a rep for the cruise told FOX411's Pop Tarts column. "It's always an amazing time with Paula, her family and fans. If she goes – we go."
Reporting by RAHA LEWS
Paula Deen Dropped by Target & On 'Pause' at QVC While Fans Show Support
Timothy Hiatt/Getty
updated 06/27/2013 AT 05:15 PM EDT
•originally published 06/27/2013 AT 12:45 PM EDT


text:
January 10, 2008
12 comments:
Glad to hear Carter is resting better.ReplyDelete
Glad to hear he's better, hope you have a great time tonight!ReplyDelete
Glad to hear that everyone got a good night's sleep! Love Olive Garden!ReplyDelete
Glad Carter is doing better and you guys are getting some rest. Enjoy your soup/salad/breadsticks tonight!ReplyDelete
SlowMo and I are totally jealous...we love to go the OG for their bottomless soup & salad!!!!!ReplyDelete
Glad Carter's doing better!!
Oooo, Deliverance had one of those, and it healed up. So glad you are both feeling better.ReplyDelete
Ummm OG, what soup do you get? I love the Pasta Fagoli....ReplyDelete
Oh yeah--what's Fintering?ReplyDelete
Yummo -- sounds good to me! Hope you had a nice time.ReplyDelete
Glad to hear Carter rested well. What a trooper!
Ok, I'm dumb. I had to read through the comments twice to figure out what OG was. I get it now! I love Land's End! I will only buy swim suits from them.ReplyDelete
Oooooh, Natalie had a perforated ear drum once. It was nasty (I won't get graphic). Glad Carter slept well!ReplyDelete
I'm glad he's feeling better, my oldest son had that once and it was NOT FUN! *hugs*ReplyDelete

subset: commoncrawl


text:
Expanding Use of NGS Has Largely...
Developers of DTC Genetic Testing Are...
As Immunotherapy Revolutionizes the Cancer Treatment...
LC-MS Gains Favor Due To the...
Kadmon to develop ribavirin prodrug candidate while Valeant gets ribavirin for Central Europe.[alexfiodorov-Fotolia.com]
Valeant Pharmaceuticals and Kadmon Pharmaceuticals inked two separate agreements, worth a combined $12.5 million up front, covering the development and/or marketing of the hepatitis C drug ribavirin and the clinical-stage ribavirin prodrug candidate taribavirin. The deals come within a few days of Kadmon buying out Three Rivers Pharmaceuticals, which already markets the hepatitis C drugs Infergen™ (consensus interferon), Ribasphere® (ribavirin, USP), and RibaPak® (ribavirin).
The first new deal gives Kadmon an exclusive, worldwide license (excluding Japan) to taribavirin, which has successfully completed a Phase IIb trial for the treatment of chronic hepatitis C. Under terms of this agreement Kadmon will pay Valeant $5 million up front in addition to development milestones and future sales royalties.
The second agreement gives Valeant exclusive rights to all Kadmon dosage forms of ribavirin, including its 200 mg, 400 mg, and 600 mg capsules and tablets, in Poland, Hungary, the Czech Republic, Slovakia, Romania, and Bulgaria. Valeant paid Kadmon $7.5 million for the ribavirin portfolio and will source the products from Kadmon.
At first glance the combination of these two deals may seem counterintuitive. Valeant is passing further development of its ribavirin prodrug candidate virtually worldwide to Kadmon but is instead taking on rights to a marketed ribavirin portfolio in central Europe. However, as Valeant's CEO, J. Michael Pearson, points out, while further development of taribavirin in house was halted in 2009 until a partner could be found, the firm wants to keep its hand in the branded generics market for hepatitis C drugs in some territories. "While participating in product development in the overall hepatitis C market no longer fits within our corporate development strategy, ribavirin could be a significant product for our branded generics portfolio in Central Europe."
Kadmon, meanwhile, is making a more obvious push into the hepatitis C market globally, both through its deal with Valeant and with its recent acquisition of Three Rivers. "Kadmon is building upon its commercial platform in hepatitis C through expanded global distribution and the addition of complementary products," notes Samuel D. Kalsal, CEO. "Our agreements with Valeant achieve milestones for both of these objectives. Taribavirin completes our ribavirin franchise and will ensure its future sustainability and growth. We have also expanded our global distribution network for ribavirin into markets in which Valeant is a leading provider."
To save this item to your Favorites,
log into GEN Select.
We'll be sure to take you back here after you do.
Not a member of GEN Select?
To comment on this article,
log into GEN Select.
We'll be sure to take you back here after you do.
Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today's life science tools and technologies.
You're all set! Thank you for subscribing to GEN Highlights.
Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?
Be sure to add [email protected]
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2016 Genetic Engineering & Biotechnology News All Rights Reserved


text:
We love what creativity brings to the world. It makes us human, adding a richness to our lives, bringing ideas, imagination and beauty. We dream of a world alive with creativity, where people are free to explore and express new ideas.
See more of what 'creativity' means to people around the world
Creativity has always been at the heart of human development. It has shaped our thinking and inspired our imaginations. We are proud of the role we have played in applying digital technologies to creativity. We are part of a generation that is creating powerful new tools of connectivity and expression that influence every aspect of the human experience.
See more about our business
'Open up. Sense more.' is the attitude that drives and inspires us to do new things. To imagine. To explore. To make. To push ourselves forward, individually and together.
We are 'for a creative world' and this underpins everything we do. It encourages us to be ambitious and innovative for our customers.
See more about our people


text:
Top Definition
A sex god. He is known for a large penis and his hot body
Wow, that kid is such a EHAB!!
από jordan cimiluca 8 Δεκέμβριος 2010
Trending Now
Can you define these popular missing words?
The name of a very famous egyptian popstar. His last name is tawfik, was also spelt tawfeeq, tawfik, tawfeq.
Ehab Tawfik's latest album, Hobbak Alemmini, was very good
από cooliematthew 4 Νοέμβριος 2005
An acronym for Everyone Has AIDS Bitches. It is a great word to use in an obnoxious tone in large public places and should be written in places with the periods to drive people crazy trying to figure it out.
Randomly Shout "E.H.A.B.!"
από Vito Oliveri 22 Δεκέμβριος 2006
Slang for a penis, dick, or massive erection.
I've got a raging ehab right now.
Dude, stop being such an ehab.
Dude, stop being such an ehab.
από 2124912419 30 Σεπτέμβριος 2010
A worthless piece of trash, an Osama bin laden looking drug dealer with a small dick. No one really likes Ehab. Ehab usually hangs out with his dumb ass friends. He thinks he's so cool and smart but he's not. He also thinks he's SOOO attractive and can get all the girls but he can't because he has a small dick and no one likes him and all he does is ask for nudes and smoke weed. If you know Ehab Khara you're a very unlucky person
Ehab looks like Osama bin laden and smokes weed everyday with his leprechaun friend.
από JacobIsTrash 10 Ιούνιος 2016
When someone gets too much junk off Ebay simply for the thrill of "winning"
My friend had Purchased 50 new item off Ebay in just four days! I called for an intervention and we took her EHab
από Lorrrie Bensky Smith 22 Μάιος 2016


text:
Quadruple Helices Appear To Have Role...
Expanding Use of NGS Has Largely...
Wall Street Decline Takes Its Toll...
LC-MS Gains Favor Due To the...
Cells are miniature laboratories that allow scientists to study key biological processes. Thus, they may provide a more natural way to assess the in vivo effects of drugs.
According to Visiongain, the market for cell-based assays exceeded $2 billion in 2012, and is predicted to quadruple to $8 billion by 2022.
New developments in this arena include getting back to basics by utilizing phenotypic screening for drug development. Additionally, employing patient cells and differentiating stem cells into defined cellular lineages are emerging as key strategies for assessing therapeutic responses. Technological advances include novel approaches for tackling the barrier of how to differentiate stem cells into specific cell types as well as integrating the speed and multiparameter assessments of flow cytometry with digital microscopy to perform phenotypic and functional analyses simultaneously.
Despite the rapid advances and focus on target-based drug discovery, the lion's share of new first-in-class small molecule drugs (approved 1999–2008) were identified using the earlier method of phenotypic screening, notes Gary Allenby, Ph.D., business director at Aurelia Bioscience, a bioassay screening and development CRO in the U.K.
"Some compare phenotypic drug discovery versus target-based drug discovery as serendipity versus constrained research. In reality, examining the pharmacological properties of the same compound in different assays can allow greater insight into the mechanism of action to better understand the target's biology. We employ a number of different phenotypic assays," says Dr. Allenby.
"Label-free assays for screening are a very useful example. In the last five years, more investigators have become interested and excited about this technology. We see this as being implemented more and more, especially to differentiate between G-coupled protein receptors (GPCRs). One can measure responses in native or physiologically relevant systems including primary human or animal cells.
"You don't have to overexpress or amplify via genetic modifications. This is a great help for understanding the molecular pharmacology of a receptor in its natural environment. Also a recombinant system doesn't necessarily have the natural coupling or even engage the correct signaling pathways. Label-free assays allow measurements such as changes in cell shape, movement, and translocation of proteins into or out of the measurement window (~100 nanometers). The criticism of these assays is that it's a black-box approach and one doesn't know if the ligand causes direct or indirect effects."
Another cell-based assay Aurelia employs is the fluorescent imaging plate reader (FLIPR) technology. "We have employed FLIPR in a range of assay formats, readouts, and targets, including GPCRs. These can be evaluated using fluorescent methodologies in 96-, 384-, and 1,536-well plates," adds Dr. Allenby.
For the future, Dr. Allenby says that he finds the use of microfluidics combined with label-free cell biological assays to be an intriguing type of cell-based assay. "This would allow much more in-depth exploration of the boundaries of how physiological compounds affect the cell environment."
Although the last 20 years of drug development has focused primarily on target-based discovery, a more powerful and productive approach would be to look at the biological responses of individual patient cells, says Rod Benson, Ph.D., COO of Imagen Biotech.
"The industry has been caught on a wrong paradigm that has blocked efficient development of new therapeutics for many years. Instead of just looking for targets, why not assess the cells you are trying to treat? As part of that change in direction, our company is focusing new R&D efforts on traditional cell-based assays but using cells derived from patients themselves. While we are employing high-content assays to screen for therapeutic responses, the primary tissue is isolated from individual cancer patients. This is a major step in accomplishing personalized medicine," says Dr. Benson.
The company has procured grant monies and other funding to carry out its studies. It will initially target types of cancers in which cells are easily isolated and purified.
"We have begun formal collaborations with clinicians in which biopsies are performed and cells are isolated and plated for high-content screening. Using 384-well plates, we perform dose responses of single and combinations of specific therapeutics followed by assessment of cellular apoptosis or death. Even if two drugs are equally effective against a cancer of a particular patient, it is important to see at what level they are effective. Obviously, if one works at 1 nanomolar concentration and the other at 100 nanomolar, the drug that works at the lowest concentration would be preferable," adds Dr. Benson.
The first phases of this new approach will assess many different types of cancers and select those that are easier to culture. Next, a host of therapeutics will be evaluated. Although initially targeting apoptotic responses, Dr. Benson sees the possibility of using many other cell-based assays.
"One could measure signs of inflammation in cells (such as stickiness), assess phenotypic endpoints, or employ any traditional high-content, cell-based assay. Another strategy to consider for the future is using phenotypic screens of patient cells to test natural products for their ability to treat cancer or other diseases. For example, products derived from plants and marine sources could also be assessed to identify candidates that are more natural therapeutics for individual patients."
Plate-based, high-content imaging readers provide a sophisticated analysis of adherent cells. However, many cells are not adherent. A new technology geared especially for the analysis of nonadherent cell populations combines the high-throughput functional insights of microscopy with the robust multi-parameter assessments of flow cytometry.
"Our company recently acquired the technology of Amnis that included the ImageStream® Mark II and FlowSight® imaging flow cytometers," reports Blaine Armbruster, Ph.D., senior product manager, discovery and development solutions at EMD Millipore, a division of Merck KGaA.
"This is a breakthrough technology that combines the power of digital fluorescence microscopy with the sensitivity and speed of flow cytometry to allow applications that weren't possible before." Dr. Armbruster notes that suspension cells can be imaged at up to 60× magnification to analyze highly heterogeneous samples as well as rare sub-cell populations at speeds up to 5,000 cells per second. The technology allows both phenotypic and functional analyses to be performed simultaneously using up to seven lasers and 12 images per cell.
There are a number of important applications. "One of the challenges of nonadherent cell populations, especially those being analyzed from blood, is determining individual versus clumps of cells," says Dr. Armbruster. "Sometimes cells just aggregate, but at other times an immune response stimulates cell–cell interactions that are important to identify and characterize. This technology not only allows easy differentiation among such cell populations but also tumor cells that may be a more rare population in blood. It also can be applied to study co-localization of proteins within cells. This has not been possible with flow cytometry alone."
For the thousands of images generated, the company's INSPIRE® and IDEAS® software are utilized for data mining. "Data analysis is designed to be intuitive and straightforward," explains Dr. Armbruster. "For example, one can click on a dot in any plot to see the corresponding image of the cell or click on a histogram bin to view all the cells within that area. One can also gate specific populations seen in dot plots to hone in on the resulting populations to validate results. Overall, it provides a great cell-based assay for generating key information on populations of cells not accessible before."
To save this item to your Favorites,
log into GEN Select.
We'll be sure to take you back here after you do.
Not a member of GEN Select?
To comment on this article,
log into GEN Select.
We'll be sure to take you back here after you do.
Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?
Be sure to add [email protected]
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2016 Genetic Engineering & Biotechnology News All Rights Reserved


text:
EAST PALESTINE - After a decorated high school track career, East Palestine senior high jumper Chloe Snyder will take her ablilites just up the road to Youngstown State University next fall.
Snyder will recieve a partial scholarship from YSU, contingent on her performance this spring at East Palestine.
"It's a huge thrill to be going to Youngstown State," Snyder said. "I can't wait to high jump at the college level."
Once on campus, Snyder will compete for head coach Brian Gorby, who is entering his 23rd year with the program. From 2004-2006 Gorby directed the Penguins to five out of a possible six Horizon League Championships.
The Penguins train at the new Watson and Tressel training site, which served as host to the 2012 Indoor Horizon League Championships.
Snyder has made a handful of visits to campus, and came away very impressed.
"The facilities and the coaching staff up there are incredible," Snyder said. "I can't wait to get started."
First though, Snyder will concentrate on finishing her Bulldog career on a strong note. She will be trying to add to a stocked resume that includes the school high jump record, and a district title in the high jump her sophomore year. In all, Snyder, has collected seven career first place finishes in the high jump, including a pair of ITCL championships and three straight Coulumbiana County titles.
"This is my last year, so I'm dreaming big," said Snyder. "I have my sights set on state."
While the high jump is her main event, Snyder has also competed in the long jump and 400 relay for the Bulldogs.
"Chloe is an extremely hard worker, and is very talented at whatever she sets her mind to" coach John Stephens said. "Not only does she work to improve herself, but she is out at practice everyday looking for ways to help the younger girls get better. She has been a tremendous asset to this program as a mentor."


text:
Sofia Vergara
Move over Salma Hayek, there's a new busty Latina bombshell in town. Well, Sofia Vergara isn't exactly new -- she's been in show business as either a model, host or actress since she was 17 -- but only now is she gaining mainstream recognition in the United States. With her scene-stealing role as Gloria, the spicy matriarch on ABC's runaway hit Modern Family, Vergara is one of the most deft comedic actresses on television, and she has an Emmy nomination to prove it.
In addition to being named among AskMen's Most Desirable Woman 2012, she was just named the United States' highest-paid television actress by Forbes.
In addition to being named among AskMen's Most Desirable Woman 2012, she was just named the United States' highest-paid television actress by Forbes.
AppealSofia Vergara is a sex symbol of the highest order. Blessed with the proportions of a blow up doll on steroids, the busty Colombian is one of the sexiest women in show business. With full lips, cascading hair and a body that won't quit, Vergara has charmed everyone from Jamie Foxx to Tom Cruise. Even after giving birth to her son (she did so when she was 20), Vergara has managed to maintain better curves then a Roy Halladay complete game. With her career finally taking off, Vergara is proving that she's as charming as she is stunning. On a recent appearance on the Tonight Show, she had Gerard Butler drooling on national television and outwitted Jay Leno himself. On second thought, our 4-year-old nephew can outwit Jay Leno.
SuccessAfter being discovered as a teenager by a photographer on a Columbian beach, Sofia Vergara has parlayed her jaw-dropping beauty into a string of film and television roles that call for, well, jaw-dropping beauty. But bit parts as "the exotic latina" in films like Big Trouble, Soul Plane, Lords of Dogtown, and National Lampoon's Pledge This! do not a successful career make.
Just when it seemed like Vergara would be destined for a career as eye candy, she was cast as Ed O'Neil's much younger wife in ABC's monster hit sitcom Modern Family. As the quick-witted, headstrong Gloria, Vergara proved that she's a lot more than just cleavage and a smile, and has been rewarded for her scene-stealing performance with a nomination for best supporting actress at the Emmys.
Since then, Sofia has lent her talents to a number of films from The Smurfs (2011), The Three Stooges (2012), Escape From Planet Earth (2012), and Machete Kills (2013), the sequel to Robert Rodriguez's highly entertaining 2010 action film Machete.
Sofia Vergara BiographySofia Margarita Vergara was born in Barranquilla, Colombia, and as a child her future status as a global sex symbol was no more than a distant fairytale. Raised as a devout Catholic, Vergara was married when she was only 18, and had her first and only son just one year later. All this while Vergara was studying dentistry, and with just one year left in her schooling, was discovered by a photographer on a Columbian beach. Soon, modeling opportunities presented themselves, with Vergara appearing in commercials to help support her family, despite being in constant conflict with her religious beliefs.
sofia vergara makes a name for herselfSofia Vergara's marriage didn't last long, and when it ended, the fledgling model packed up and moved to Bogoto, Columbia, to pursue an increasing amount of opportunities in show business. Her big break came as cohost of the travel show Fuera de Serie (Out of the Ordinary), which gave her ample exposure in the U.S. after it aired on Univision.
Sofia Vergara's exotic sex appeal made her a highly sought after bikini model as well, and in no time, Hollywood was banging at her door. In 2002, Vergara made her big-screen debut opposite Tim Allen, Renee Russo and Zooey Deschanel in the comedy Big Trouble. Though Vergara was hailed for her natural comedic abilities, the role was limited at best, and led to Vergara being typecast as the token buxom Latin woman in a variety of films and television shows including Chasing Papi, The 24th Day, Soul Plane, Lords of Dogtown, Baywatch, My Wife and Kids, and Entourage.


text:
Hey everyone,Thanks for your votes!Last week was a tough one for us, but I'm really proud of Amber and how she pulled through. We ended up having no rehearsal time. The quickstep you saw on the show was honestly the first time we did it from beginning to end. Crazy, right? In total, we did maybe three hours on that quickstep. Neither of us was sure how it was going to ...
Read More >
Other Links From TVGuide.com
Location, ST | website.com


text:
"Actress Christina Applegate and fiancé, musician Martyn LeNoble, welcomed daughter Sadie Grace LeNoble on Thursday, Jan. 27, 2011 in Los Angeles," the spokesperson said in a statement. "Mother and daughter are doing great."
Adds someone close to the proud parents: "She's a beautiful little girl, and they are so happy and in love with her."
Applegate, 39, and LeNoble, 41, have been dating for nearly three years and became engaged last Valentine's Day. The pregnancy was announced in July.
In August, Applegate told PEOPLE: "I'll probably be a little bit hippie and a little bit Type A. I'll take from what my mother did, which was way hippie and like, 'Do what you wanna do,' and bring some things that I know from watching my friends raise their kids. An amalgamation of sorts."
See what other readers have to say about this story – or leave a comment of your own


text:
Source: The Wall Street Journal
quote: Why should a smart watch reamin just a plastic gimmick and not become a fashionable accessoire?
quote: why not buy a watch which does not only look good but also is smart, too?
quote: You assume the Apple watch or Google watch are made out of plastic and look ugly


text:
Top Definition
When you slap someone with your soft circumcised penis causing a small red mushroom shaped mark on the skin from the head of the penis.
Dude I mushroom slapped her last night right on the cheek, it left a red mark!
от Aiden07321 06 юни 2010
Trending Now
Can you define these popular missing words?
To awaken one under the influence of psilocybin from incoherence with a quick slap of the hand to the face
Tony mushroom slapped Albert so as to awaken him from his incomprehensibly negative, drug-induced rant. (But Bert just became further enraged and had to be wheel chaired to bed.)
от Alphonse Drizzny 05 януари 2009


text:
Top Definition
Pretty, caring person. Very pretty and is easy to talk to. May seem shy at first but then when you start to talk to her you will be suprised. You will be lucky to find a Dublynne they are very rare!
Lol that girl looks lush she must be a dublynne
โดย WhoAreYouIDontCare 17 ธันวาคม 2013
Trending Now
Can you define these popular missing words?


text:
Tweaking synchronization protocols with GnRH, CIDR, or through Double Ovsynch all boosted pregnancy rates.
by Ellen R. Jordan
The author is a professor and extension dairy specialist with Texas AgriLife Extension Service, Texas A&M University system.
This past summer researchers from around the world met in Montreal, Quebec, Canada at the joint annual meeting of the American Dairy Science Association (ADSA), the American Society of Animal Science, and the Canadian Society of Animal Science. During the meeting, a total of 810 oral presentations and 1,086 posters were on display for an "early look" at future dairy research that will be reported in technical journals and conferences in the next two years.
For dairy managers and consultants that have internet access, it would be beneficial to become a member of ADSA which allows you to access the monthly electronic Journal of Dairy Science and Scientific Proceedings of Animal Conferences or S-PAC (34 conferences with 279 proceedings are available online with key word searches by author or topic area). Contact ADSA at email@example.com on how to join.
The following are summaries of some of the abstracts presented on dairy reproduction along with comments and a contact author for additional information.When a P<0.01 is reported, it means that 99 percent of the time the same results would be expected if the research was repeated. Because of the large number of cows required for reproductive research, some studies with a tendency (P<0.10) are reported. That means that 10 percent of the time when these studies are repeated different results will be obtained.
Resynchronization strategies
Presynchronization has been coupled with estrous synchronization programs to boost the number of cows becoming pregnant at first insemination by increasing the number of cows in the correct phase of the estrous cycle. Pregnancy results from resynchronization after nonpregnancy diagnosis have not met expectations, possibly as a result of the variability in the stage of the estrous cycle.
In an attempt to identify a resynchronization strategy to improve fertility without elevating the time to subsequent insemination, cows in two herds in Arizona and California were assigned to one of three treatment protocols. At 32 days postinsemination cows were randomly assigned to the resynchronization protocols. All cows went through a nonpregnancy diagnosis at approximately 39 days postinsemination. The resynchronization protocols were:
1. Control (n=386) - At nonpregnancy diagnosis on Day 39, cows were given the first GnRH of a Cosynch-72 protocol. They received prostaglandin seven days later and were bred and given a second dose of GnRH three days later.
2. GGPG (n=357) - On Day 32 postinsemination, these cows were given GnRH. At nonpregnancy diagnosis on Day 39, they received the same Cosynch-72 protocol as the control groups.
3. CIDR (n=316) - The nonpregnant animals in this group also began the Cosynch-72 protocol on Day 39. In addition, a CIDR was inserted at the time GnRH was given. The CIDR was removed seven days later, at the same time of the prostaglandin injection.
More cows were pregnant in both the GGPG (33.6 percent) and CIDR (31.3 percent) groups than in the control (24.6 percent) at the nonpregnancy diagnosis approximately 39 days postinsemination. There was an interaction with body condition score. More thin cows (BCS?2.75) became pregnant in the CIDR group, while more moderately conditioned cows (BCS>2.75) became pregnant with the GGPG treatment.
Comment: Results from this study indicate that the number of cows becoming pregnant after a nonpregnancy diagnosis can be improved either by adding an injection of GnRH seven days prior to the nonpregnancy diagnosis or by adding a CIDR into the Cosynch-72 program. The success varies with the body condition of the cows.
Contact: Todd Bilby, Texas A&M AgriLife Research and Extension; phone: (254) 968-4144; e-mail: email@example.com
Economics of resynchronization
The three resynchronization protocols described in the preceding research were evaluated to determine if the extra cost associated with GGPG and the CIDR were economically beneficial. The average costs used were: prostaglandins, $1.50; labor, $10 per hour; GnRH, $1.50; CIDR, $10 each; and pregnancy value, $275. The average cost for the control, GGPG, and CIDR treatments were $5.40, $10.66, and $14.85, with an average return per cow of $55.04, $73.29, and $60.64.
For the average costs, these returns were not significantly different (P=0.17). However, when 81 different scenarios were developed by varying the cost of the GnRH (range: $1-$5), CIDR (range: $5-$15), and pregnancy value (range: $100-$500); the average return was greatest for the GGPG protocol ($36.40), intermediary for the CIDR treatment ($33.25), and lowest for the control group ($27.50).
Comment: The economic evaluation indicates that adding either an extra GnRH injection (GGPG group) or CIDR insert (CIDR group) to CoSynch-72 raised the return per cow when resynchronizing nonpregnant cows.
Contact: Ricardo Chebel, University of Minnesota; phone: (612) 625-3130; e-mail: email@example.com
Double Ovsynch for resynchronization
In this trial, resynchronization was accomplished by using either a Double Ovsynch protocol or an Ovsynch protocol. The cows were randomly assigned to two groups and received varying treatments relative to the previous artificial insemination date. The groups were synchronized as follows based on the days from initial insemination:
Double Ovsynch (n=962): d22 (Day 22), GnRH; d29, ultrasound and nonpregnant animals given prostaglandin; d32, GnRH; d39 GnRH (begin Ovsynch-56); d46, prostaglandin; 56 hours later GnRH; and rebred 16 hours later.
Ovsynch (n=956): d32 GnRH (begin Ovsynch-56); d39, palpation and prostaglandin for nonpregnant cows; 56 hours later GnRH; and rebred 16 hours later.
All cows in both groups were then ultrasounded 29 days postinsemination to determine pregnancy status, and 74 days after insemination they were palpated to reconfirm pregnancy. More cows receiving the Double Ovsynch protocol (38.5 percent) conceived to the resynch insemination than those treated with Ovsynch-56 (30.0 percent). Pregnancy loss between the ultrasound at Day 29 and palpation at Day 74 did not differ between the Double Ovsynch (13.9 percent) and Ovsynch-56 (17.5 percent) treatment groups.
Comment: Using a Double Ovsynch protocol improved the percentage of cows becoming pregnant after a resynchronized insemination; however, it required an additional seven days and three hormonal injections compared to the Ovsynch-56 treatment.
Contact: Paul Fricke, University of Wisconsin; phone: (608) 263-9412; e-mail: firstname.lastname@example.com


text:
Top Definition
When you believe yourself to be more than you actually are.
Charles thought he was a king little did he know, he was living a deray fantasy life.
от MadameXButterfly 22 февруари 2015
Trending Now
Can you define these popular missing words?
Typically a tall, dark and handsome male. Gorgeous smile. Young, intelligent cannabis connoisseur.
Girl: "Did you see that guy?! .. he was a total DeRay!"
от daddymijo 10 декември 2013


text:
Closed Captioned
Sweet, buttoned-up and decidedly girly, Christine's blouse designs are fresh and unique. You'll learn how to piece together an exclusive class pattern and create two flattering variations. Then, see how to mix and match sleeves, collar and bodice designs to make them your own! Discover how to include a curved collar, pintucks, buttonholes, interfacing, sleeve insertion, and bust and back darts to your blouse. For the sewists who are ready to add tops to their repertoire, Christine gives you step-by-step guidance as well as skills you can use in all your future projects!
Meet Christine Haynes, creator of the Sassy Librarian Blouse and learn about the Craftsy platform.
Christine goes over what supplies you'll need and how to find your size.
Christine goes over fabric, pinning, interfacing and cutting with easy-to-follow instructions.
Mark your fabric and create darts with Christine's help.
Learn marking and sewing techniques for this view by creating bust and waist darts, as well as tucks down the front.
Christine shifts the focus from the front to the back to help you create pleats, seams and zigzags.
Learn how to add interfacing, trim and topstitch to your collar with Christine's easy-to-follow instruction.
Learn how to add a tab or bow to your sassy blouse.
Christine teaches you how to trim and attach your blouse facings.
Add sleeves to your blouse with Christine's helpful instruction and tips. You'll also trim the seam allowance and press your blouse.
Learn to sew the sleeve band before folding and pressing the armband. Finish off this part of your garment with a little topstitching.
Don't hem and haw! You're almost done. Sew a placket on your blouse with Christine's help.
Add the finishing touches to your blouse with buttons and bows. Christine explores different closure options with you.
"Thank you Christine! I have learned so much thanks to your detailed and clear instructions. I have never tackled collars, darts or pleats before and now so many more patterns are open to me. The blouse pattern is great and I love how mine turned out."
- cindy1949453


text:
Police say a car reached speeds of 40 m.p.h before the teens were thrown off.
No email address was supplied by
To complete your registration on this site, please supply an address.
Please confirm or modify the email address to which you will have subscription offers sent.
For a more personalized experience, please supply the following optional information.


text:
"A Walk in the Woods" Managing Wildlife Habitat
From Outdoor JournalMore on this episode »
Few things are more satisfying for landowners than seeing deer, wild turkeys and other wildlife on their property. And few things are more important to deer and other wildlife than engaged landowners. About 80 percent of Vermont's forested habitat is privately owned, and as more land is lost to development each year, the importance of the remaining habitat has steadily grown. With the help of organizations like the Vermont Woodlands Association, the Vermont Fish and Wildlife Department hosts workshops that educate landowners on the benefits of actively managing wildlife habitat.


text:
As a cassandra sangue, or blood prophet, Meg Corbyn can see the future when her skin is cut—a gift that feels more like a curse. Meg's Controller keeps her enslaved so he can have full access to her visions. But when she escapes, the only safe place Meg can hide is at the Lakeside Courtyard—a business district operated by the Others.
Shape-shifter Simon Wolfgard is reluctant to hire the stranger who inquires about the Human Liaison job. First, he senses she's keeping a secret, and second, she doesn't smell like human prey. Yet a stronger instinct propels him to give Meg the job. And when he learns the truth about Meg and that she's wanted by the government, he'll have to decide if she's worth the fight between humans and the Others that will surely follow.
"A stunningly original yarn, deeply imagined, beautifully articulated and set forth in clean, limpid, sensual prose."—Kirkus Reviews
"An amazing novel."—Fresh Fiction
"Written in Red isn't just the best urban fantasy of the year, it may be one of the best ever."—All Things Urban Fantasy
"A gripping novel from start until finish…In the end, Ms. Bishop leaves readers wanting more."—Night Owl Reviews (Top Pick)
"Fast-paced action, well defined characters and an imaginative storyline make for a fine paranormal read."—Monsters and Critics
Meg Corbyn and I have something in common: We see in images.
Let me show you how the Others and their world came into being.
Image, sometime in the past decade: A solid block of buildings on a downtown street. Suddenly there is a gap and a wrought–iron gate that reveals a grassy courtyard. Thought: Who lives in those buildings hidden away from all the people walking past that gate? What secrets live behind ordinary facades?
Thought after reading some urban fantasy novels, circa 2006–2007: I'd like to write a story about werewolves and vampires someday.
Image, circa 2006, cemetery in Virginia: family plots defined by fences. Thought: Do the fences keep something out or keep something in? Who lives in those underground chambers?
Thought, circa 2007, after talking with some other women about teenage girls who cut themselves: What if a girl saw a vision of the future when she cut herself?
Thought: I'd like to write a story about werewolves and vampires someday.
2007: I have an idea for a light and fluffy urban fantasy story. My interest holds for about the 30 minutes or so it takes to write a few paragraphs and realize the idea had played itself out. But something remains: the name Simon Wolfgard.
Thought, circa 2008: I'd like to write a story about werewolves and vampires someday.
Image, circa 2009, in Victoria, British Columbia: A market square with boutique shops and an interior space that has a platform for live music as well as benches and tables where people can sit. Thought: The Others (whoever they are) would like a place like this in their Courtyard (whatever that is).
Image, circa 2010, driving around Forest Lawn Cemetery in Buffalo, New York. Thought: The Others (whoever they are) would like it here.
Thought, circa 2010: What if the werewolves and the vampires and the other supernaturals didn't start out human? What if they sprang from a different evolutionary tree, one that gave them the ability to mimic other predators and absorb the qualities that enhanced their success in bringing down prey? What if they have been the dominant predators since before the time of the dinosaurs, earth natives who change with the world and the creatures living in it so they remain the dominant predators? What if they control most of the world? What if humans are a minority species who are dependent on the tolerance of the Others for their survival?
There is always that one thought, that one moment, that acts like a magnet, pulling together random images and ideas and giving me the first catch–my–breath vision of a world and characters and story.
A re–imagined Earth with predators who, for the most part, view humans as just another prey animal. Contemporary human cities with hitches and quirks in the available technology because people have to work with the resources they can get. Courtyards, the park–like residences of the earth natives assigned to keep watch on human cities. And girls who see prophecies when their skin is cut.
What happens when the wants and needs of earth natives, humans, and blood prophets collide?
The answer is written in red.


text:
Look back at terrorism in America
POSTED: 02:57 PM PDT Apr 15, 2013 UPDATED: 08:16 AM PST Jan 05, 2015
As suspected Boston Marathon bomber Dzhokhar Tsarnaev's trial begins, take a look back at the history of terrorist attacks on home soil.
The views expressed are not those of this company or its affiliated companies. Please note by clicking on "Post" you acknowledge that you have read the Terms Of Service and the comment you are posting is in compliance with such terms.blog comments powered by Disqus


text:
North Hollywood, CA, USA and Barcelona, Spain – June 14, 2010 – The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, has concluded the first-of-its-kind inaugural Myeloma Summit meeting - nearly 70 of the world's leading experts in myeloma and related blood cancers charting the future of myeloma treatment and care. New drugs that modulate the immune system and target features unique to a myeloma cell have extended remissions for patients while providing a good quality of life. However, the availability of a growing number of options raises questions about when to use which treatments for which patients:
Among the issues discussed:
The Working Group will issue consensus statements on these and related issues to help guide treatment, and recommend and implement clinical trials that can answer remaining questions fastest to provide the most comprehensive recommendations to-date for the treatment and management of myeloma.
Brian G.M. Durie, M.D., chairman of the IMF and co-chair of The International Myeloma Working Group Summit commented: "Given the wide range of experience within the group, the discussions clearly lay the groundwork to move beyond long term remissions and begin charting a roadmap for an actual cure. My goal is to identify the first group of patients most likely to respond to a cure."
The Myeloma Summit was scheduled between two of the year's largest cancer conferences, the American Society of Clinical Oncologists (ASCO) in Chicago and the European Hematology Association (EHA) in Barcelona. Newest findings focus on a shift in care toward continuous treatment to maintain remissions. As the IMF previously noted, studies reported at ASCO demonstrate advantages to continuous treatment with Revlimid® regimens and with Velcade® regimens. Adding to these findings, at EHA, a landmark analysis from Dr. Antonio Palumbo at the University of Torino, Italy, demonstrated that patients 65 to 75 years old, given initial and then continuous treatment with a Revlimid-based regimen, had a 69% reduction in the risk of disease progression compared to those who received only an initial fixed course of Revlimid.
The Myeloma Summit concluded with the presentation of the 2010 Robert A. Kyle Lifetime Achievement Award, this year going to Dr. Joan Bladé of the Clinic Barcelona Hospital Universitari. Dr. Bladé is co-founder of the Spanish blood cancer research consortium PETHEMA and he helped develop the "Bladé Criteria" to quantify response to myeloma treatments.
Myeloma, also called multiple myeloma is a cancer of cells in the bone marrow. Once a rare disease of the elderly, multiple myeloma is being diagnosed in growing numbers and in increasingly younger people. Each year approximately 20-thousand new cases are diagnosed in the United States. New treatments have extended remissions for many patients, measured in years not months, with a good quality of life.
The International Myeloma Foundation is the oldest and largest myeloma organization, reaching more than 195,000 members in 113 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses in four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 200 educational seminars worldwide, maintains a world-renowned hotline, and operates Bank on a Cure®, a unique gene bank to advance myeloma research. The IMF can be reached at (800) 452-CURE. The global website is www.myeloma.org.
Contact: GL BioCom Partners
Los Angeles/Barcelona: Stephen Gendel +1 212-918-4655
New York: Jennifer Anderson +1 212-918-4642


text:
Saucony Adapt Trail Running Shoe - Womens
Sorry, this item is sold out!
Looks like you've got more shoe shopping to do - have fun!
Looks like you've got more shoe shopping to do - have fun!
Item # 247972
If you demand adventure and even more comfort durability and responsiveness, discover how exciting this can be in the Saucony® Adapt trail running shoe.
This women's running shoe is best for the neutral runner. What is pronation?
- Mesh and synthetic upper
- Injection molded EVA midsole for cushioning and durability
- Non-visible grid system provides stability at impact
- Propel technology in the heel absorbs shock and ensures a level smooth ride on rough terrain
- HRC Strobel board for extra comfort
- XT-600™rubber outsole with triangular lug design for all terrain types
- Imported
- View more Saucony
*Your pronation type is determined by the natural motion your feet apply throughout your running gait. When you pronate your foot rolls from either the outer edge, inner edge or not at all. If your foot rolls to the outer edge when you run, you are an underpronator, if it rolls to the inner edge you are a overpronator and if your foot doesn't roll at all you are a neutral or stable runner.
Find the the best running shoe for your pronation type :
By: Beliz
Location: King of Prussia, PA
February 16, 2013
Nice Athletic Shoe
"This shoe was a nice shoe for working out or just walking in. I can wear them in all weather and they are very comfortable. They are a nice low ride so they didn't bother the back of my ankle. Also there was plenty of cushioning."
By: AnaDSW
Location: Chicago, IL
February 07, 2013
Great jogging
"Wow, so comfy to work out, better on the treadmill."
By: spikebabs
Location: NJ
February 07, 2013
"I love this Saucony Running Shoe...very comfy, lightweight and sturdy. I love it so much I'm thinking of purchasing another pair soon to have when these wear out!"
By: MariaJean
January 25, 2013
Click anywhere to close this.


text:
on December 4, 2012 - 12:01 AM
A popular food for thousands of years, olives pack a powerful nutritional punch along with their rich flavor.
One of the oldest cultivated trees, the olive tree, along with its branches, fruit, and oil – permeates legend, history and palates around the world. A universal symbol of peace, glory and abundance, the olive, native to Asia Minor, was first cultivated in the Mediterranean during the fifth century BC.
According to mythology, Zeus promised to name the region of Attica that contained what would become the city of Athens for the god or goddess who brought the most useful invention. Poseidon brought a warhorse and Athena brought the olive tree, useful for heat, light, shade, food and medicine. Legend has it that the olive tree that grows at the Acropolis in Athens comes from those first roots.
The facts
Olives are the fruit of the Olea europea tree. There are thousands of cultivars, but only a few are grown abundantly, both for olives and olive oil. A few important cultivars are arbequina, bosana, kalamata, manzanilla and mission. Some olives may be eaten right from the tree, but most sold commercially are cured with water, brine or lye.
Regardless of variety and processing, olives are high in healthy, cholesterol-lowering monounsaturated fats and are rich in many health-protective nutrients, including an array of antioxidants. A one-cup serving packs 22 percent DV (percent Daily Value, recommended intake for 2,000 calories/day) of iron, 16 percent DV for dietary fiber, and 20 percent DV for copper for 148 calories.
The findings
Most of the olive's fat is made up of oleic acid, a monounsaturated fat associated with reduced risk of heart disease. Olives are also plump with a diverse collection of phytonutrients, including polyphenols – known antioxidants which protect against cell damage.
A study published this year in the Journal of Alzheimer's Disease found daily consumption of oil from olives as part of a Mediterranean style diet may protect against age-related cognitive decline or Alzheimer's disease. A laboratory study published in a 2011 issue of the Journal of Agricultural Food Chemistry found that olive skins contain important antioxidants that inhibit breast cancer cell growth.
The finer points
Whether canned, jarred or in an olive bar, olives are fun to explore. Sample the variety of greens, blacks, reds, sizes and textures – smooth, wrinkled, or cracked. Some are even stuffed with peppers or nuts and swimming with herbs and spices. Olives make a simple snack or appetizer on their own, or blended with olive oil, garlic and seasonings as tapenade to spread on bread or top fish and poultry. Toss them with pasta or onto pizzas and salad for a burst of flavor and nutrition.


text:
Welcome to our weekly edition of what's hot in social media news. To help you stay up-to-date with social media, here are some of the news items that caught our attention.
What's New This Week?
Facebook Timeline for Business Image Changes: On April 26, Facebook will be updating the display size of the profile picture/avatar on all Facebook pages. If you have a tightly integrated design, you should be aware of this change. Be ready to update your profile picture on April 26. The new profile picture will be 160 x 160 pixels and will sit at 23 pixels from the left and 210 pixels from the top of the page.
Facebook Syncs Email Addresses: "With your @facebook.com email address, people can email you using any traditional email system (e.g., Hotmail, Yahoo! or Gmail), and the emails will be delivered to your Facebook Messages." Facebook now syncs your email address with your Facebook name.


text:
A name of a woman who is very beautiful and very nice. You are a very lucky person to have one in your life if you do.
Boy: Wow she is drop dead gorgeous
Boy2: I know but she already has a boyfriend
Boy: Well she is very attractive and nice she is such a Brooke
Boy2: I know but she already has a boyfriend
Boy: Well she is very attractive and nice she is such a Brooke
Beküldő: anawesomedoodaha 2010. június 25.
Nice ass that's for sure.
Dude: Wow Brooke's wearing yoga pants today
Friends: *high-fives*
Friends: *high-fives*
Beküldő: aguywhoknows 2013. március 18.
Brooke is beautiful, kind and a wonderful that is more unique than any other girl, please if you ever meet someone like Brooke look after her really well she can be quite emotional at time but is the best friend and i recon she would be the best girlfriend as well, Brooke does have a hard life but she is always smiling, sometime she smile just for the sake of it so please if you meet a Brooke make her smile for real.
Me: Look at that Brooke she is so beautiful and is practically one of the best people you will ever meet
You: Really well shes amazing
You: Really well shes amazing
Beküldő: Lolboy1702 2014. november 13.
She's smart kind beautiful happy and lives life to the fullest she makes people happy and wants people to smile and be happy she might have troubles but I'm there for her she lives happily I love her very much she makes my day happy I love you Brooke
Beküldő: <3 loving you 2013. november 11.
The most amazing girl in the universe.
Brooke's kisses taste like honey mixed with sunshine.
I think Brooke's gorgeous. I want to date her, love her and marry her.
I think Brooke's gorgeous. I want to date her, love her and marry her.
Beküldő: florealis 2014. május 26.
An amazing girl who loves to live life to the fullest! Although blonde she can be very smart when she needs to be. She is very sexy and beautful. Her hair is very thick and full and many people are jealous. She like's guys whos names start with the letter M. She has a cute butt and lovely eyes. They are very blue and beautiful. She's EXTREMLY pretty and is best friends with people whose names start with the letter A. She is also very great at sports, and all guys love that about her! Guys LOVE her sense of humor, and many guys are her best friends.
Wow that girl is so cool, she's such a Brooke!
Beküldő: sexysportgirl17 2010. július 16.
Brooke's are Kind, beautiful, faithful, honest, sexy, trustworthy, sweet, has the most bright eyes and smile, her voice is soft and gentle like a wonderful summer breeze, her laugh sends shivers down my spine, the way she hugs me makes my heart pound, i trust her with my life and more importantly my heart, she loves me and i will treasure her forever. She is my girlfriend and i love her.
I love YOU Brooke!
Beküldő: Belle_Coeur 2014. május 26.


text:
The Marine Machinery, Equipment & Supplies Wholesale Lines Global Report gives Market Consumption / Products / Services for 100 countries by each Product by 2 Time series: Historic 2009- 2015 and Forecasts 2016- 2024
Whereas the main database for Marine Machinery, Equipment & Supplies Wholesale Lines covers over 200 countries, this PDF edition usually covers 100 significant countries, including:
Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, El Salvador, Estonia, Finland, France, French Guiana, Georgia, Germany, Ghana, Greece, Guyana, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Ireland, Israel, Italy, Jamaica, Japan, Kazakhstan, Kenya, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lithuania, Luxembourg, Malawi, Malaysia, Mexico, Morocco, New Zealand, Nicaragua, Nigeria, Norway, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia and Montenegro, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sri Lanka, Suriname, Sweden, Switzerland, Taiwan, Tanzania, Thailand, The Netherlands, Tunisia, Turkey, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Venezuela, Vietnam, Zambia.
In addition to data on individual countries, this report also contains a World Total, and 9 Regional Totals: Canada and the USA, Central America, South America, Europe, Eurasia, Middle East, Africa, Asia, and Oceania.
Marine Machinery, Equipment & Supplies Wholesale Lines MARKETS DATA - in US$ by Country by Product / Service by Year: 2009- 2024.
1. Marine machinery, equipment and supplies merchant wholesalers Product Lines
2. Other mechanical power transmission supplies
3. New ships and boats, excluding pleasure boats
4. New marine propulsion machinery and equipment
5. New marine supplies
6. Used marine machinery, equipment, and supplies
7. Labor charges for repair work
8. Parts installed in repair work
9. Other service receipts and labor charges
This report is from a Market database which is designed to be compatible with U.S. government databases.
NAICS / SIC coded reports and databases
For NAICS / SIC coded reports and databases, the report structures, datasets, field names, et al, are an analogue of U.S. Department of Commerce databases, and the U.S. Census databases, are designed to provide an analogue of U.S. Census data, but in a worldwide context. The products are described under their NAICS or SIC coding. This coding system classifies products within Product Codes.
These product / revenue lines codes are of course determined by the U.S. Government agencies.
FINANCIAL DATA for each Country for each balance sheet item by year 2009- 2024:
1. Total Sales
2. Pre-tax Profit
3. Interest Paid
4. Non-trading Income
5. Operating Profit
6. Depreciation: Structures
7. Depreciation: Plant and Equipment
8. Depreciation: Miscellaneous Items
9. Total Depreciation
10. Trading Profit
11. Intangible Assets
12. Intermediate Assets
13. Fixed Assets: Structures
14. Fixed Assets: Plant and Equipment
15. Fixed Assets: Miscellaneous Items
16. Fixed Assets
17. Capital Expenditure on Structures
18. Capital Expenditure on Plant and Equipment
19. Capital Expenditure on Vehicles
20. Capital Expenditure on Data Processing Equipment
21. Capital Expenditure on Miscellaneous Items
22. Total Capital Expenditure
23. Retirements: Structures
24. Retirements: Plant and Equipment
25. Retirements: Miscellaneous Items
26. Total Retirements
27. Total Fixed Assets
28. Finished Product Stocks
29. Materials as Stocks
30. Total Stocks / Inventory
31. Debtors
32. Miscellaneous Current Assets
33. Total Current Assets
34. Total Assets
35. Creditors
36. Short Term Loans
37. Miscellaneous Current Liabilities
38. Total Current Liabilities
39. Net Assets / Capital Employed
40. Shareholders' Funds
41. Long Term Loans
42. Miscellaneous Long Term Liabilities
43. Total Employees
44. Raw Materials Cost
45. Finished Materials Cost
46. Fuel Cost
47. Electricity Cost
48. Total Input Supplies / Materials and Energy Costs
49. Payroll Costs
50. Wages
51. Directors' Remunerations
52. Employee Benefits
53. Employee Commissions
54. Total Employees Remunerations
55. Sub-Contractors
56. Rental & Leasing: Structures
57. Rental & Leasing: Plant and Equipment
58. Total Rental & Leasing Costs
59. Maintenance: Structures
60. Maintenance: Plant and Equipment
61. Total Maintenance Costs
62. Services Purchased
63. Communications Costs
64. Miscellaneous Expenses
65. Sales Personnel Variable & Commission Costs
66. Sales Expenses and Costs
67. Sales Materials Costs
68. Total Sales Costs
69. Distribution Fixed Costs
70. Distribution Variable Costs
71. Warehousing Fixed Costs
72. Warehousing Variable Costs
73. Physical Handling Fixed Costs
74. Physical Handling Variable Costs
75. Physical Process Fixed Costs
76. Physical Process Variable Costs
77. Total Distribution and Handling Costs
78. Mailing & Correspondence Costs
79. Media Advertising Costs
80. Advertising Materials & Print Costs
81. POS & Display Costs
82. Exhibition & Events Costs
83. Total Advertising Costs
84. Product Returns & Rejection Costs
85. Product Service & Maintenance Costs
86. Customer Problem Solving & Customer Complaint Costs
87. Total After-Sales Costs
88. Total Marketing Costs
89. New Technology Expenditure
90. New Production Technology Expenditure
91. Total Research and Development Expenditure
92. Total Operational & Process Costs
93. Debtors within Agreed Terms
94. Debtors outside Agreed Terms
95. Un-recoverable Debts
INDUSTRY DATA for each Country for each Norm by period (Previous / Current / Forecast):
1. Supplier or Producer Market Level Prices
2. Distribution Channel Market Level Prices
3. Retail or Added Value Market Level Prices
4. User or Consumer Market Level Prices
5. Discounted & Promotional Market Level Prices
6. Plant & Equipment Average Annual Investment
7. Product Prices Market Average
8. New Product Introductions
9. Relative output of Products of a Superior Quality
10. Index of Comparative Salesforce and Selling Expenditure
11. Index of Comparative Advertising Expenditure
12. Index of Comparative General Promotional Expenditure
13. Product Adoption Rates
14. Product Sales Conversion Rates
15. Average Annual Sales Growth Rate
16. Capacity Utilization as a measure of Standard Capacity
17. Standardized Products & Services Index
18. Relative Employee Compensation Index
19. Instable Market Share as an Index of Total Market Share
20. Relative Forward Integration Index
21. Plant and Equipment Investment greater than Depreciation
22. Plant and Equipment Investment Equal to Depreciation
23. Plant and Equipment Investment Less than Depreciation
24. Plant and Equipment Investment - Unallocated
25. Plant and Equipment in Use within the range 0-3 years
26. Plant and Equipment in Use within the range 3-6 years
27. Plant and Equipment in Use within the range 6-9 years
28. Plant and Equipment in Use over years 9 old / Unallocated
29. Supplier Concentration = 8 Largest
30. Supplier Concentration = 20 Largest
31. Supplier Concentration = 50 Largest
32. Supplier Concentration = Unspecified / Unallocated
33. Immediate Wholesale & Retail Customers
34. Immediate OEM or Added Value Customers
35. Immediate User or Consumer Customers
36. Immediate Non-Specific Customers / Unallocated
37. Enterprises within the Range 1-19 Employees
38. Enterprises within the Range 20-99 Employees
39. Enterprises within the Range 100+ Employees
40. Enterprises within Unspecified Employee Ranges
41. Buyer Age Profile in the range 0-19 Years
42. Buyer Age Profile in the range 20-24 Years
43. Buyer Age Profile in the range 25-34 Years
44. Buyer Age Profile in the range 35-44 Years
45. Buyer Age Profile in the range 45-54 Years
46. Buyer Age Profile in the range 55-64 Years
47. Buyer Age Profile in the range 65+ Years
48. Buyer Profile in the AB Social Group
49. Buyer Profile in the C1 Social Group
50. Buyer Profile in the C2 Social Group
51. Buyer Profile in the DE / Unallocated Social Group
52. User Age Profile in the range 0-19 Years
53. User Age Profile in the range 20-24 Years
54. User Age Profile in the range 25-34 Years
55. User Age Profile in the range 35-44 Years
56. User Age Profile in the range 45-54 Years
57. User Age Profile in the range 55-64 Years
58. User Age Profile in the range 65+ Years
59. User Profile in the AB Social Group
60. User Profile in the C1 Social Group
61. User Profile in the C2 Social Group
62. User Profile in the DE / Unallocated Social Group
10 Products covered for over 100 Countries: 444 pages.
This database is updated monthly. An Upgrade to a full database edition is available.
Please E-mail our customer service team for more details.
This PDF Express report is a summary of the main database which contains 9743 spreadsheets and 9734 database tables. In fact the data in this Summary PDF is derived from only 300 of the 9743 datasets, and less than 10% of the data in the selected spreadsheets. For example, the main database provides market data from 1997 to 2016 and 2017 to 2044, however simply by adding the missing years would increase the number of pages fourfold – and make this PDF unmanageable.
After reading this report, if readers find that they need more data than contained in this PDF then there is a simple Upgrade process to purchase the full database edition. In addition there is a Coupon in the PDF report which clients can use to get a reduction on the price of the full database edition.
To upgrade to the full Database Edition you can use the coupon to get the upgrade edition you need at a reduced cost.
The Market for Marine Machinery, Equipment & Supplies Wholesale Lines in each country by Products & Services.
The Marine Machinery, Equipment & Supplies Wholesale Lines World Report covers:
TIME SERIES - Historic: 1997- 2016 / Current time series: 2017- 2024 / Long Term Projection: 2024-2043. Consumption given at industry / distribution channel / service or product line level.
PRODUCTS & MARKETS COVERED: As above
1 Administration, 2 Advertising, 3 Buyers - Commercial Operations, 4 Buyers - Competitors, 5 Buyers - Major City, 6 Buyers - Products, 7 Buyers - Trade Cell, 8 Competitive Industry Analysis, 9 Competitor Analysis, 10 Country Focus, 11 Distribution, 12 Business Decision Scenarios, 13 Capital Costs Scenarios, 14 Cashflow Option Scenarios, 15 Cost Structure Scenarios, 16 Historic Industry Balance Sheet, 17 Historic Marketing Costs & Margins, 18 Investment + Cost Reduction Scenarios, 19 Market Climate Scenarios, 20 Marketing Costs, 21 Marketing Expenditure Scenarios, 22 Marketing Margins, 23 Strategic Options Scenarios, 24 Survival Scenarios, 25 Tactical Options Scenarios, 26 Geographic Data, 27 Industry Norms, 28 Major City Market Analysis, 29 Capital Access Scenarios, 30 Market Cashflow Scenarios, 31 Economic Climate Scenarios, 32 Market Investment + Costs Scenarios, 33 Marketing Expenditure Scenarios, 34 Market Risk Scenarios, 35 Market Strategic Options, 36 Market Survival Options, 37 Market Tactical Options, 38 Marketing Expenditure -v- Market Share, 39 Marketing Strategy Development, 40 Markets, 41 Operational Analysis, 42 Overseas Development, 43 Personnel Management, 44 Physical Distribution + Customer Handling, 45 Pricing, 46 Process + Order Handling, 47 Product Analysis, 48 Product Development, 49 Product Marketing Factors, 50 Product Mix, 51 Product Summary, 52 Profit Risk Scenarios, 53 Promotional Mix, 54 Salesforce Decisions, 55 Sales Promotion, 56 Surveys, 57 Targets -Product + Market, 58 Technology, 59 Trade Cell Analysis.
PRODUCT CONSUMPTION - in US$ by Country by Product/Service by Year: 1997- 2016, Forecast 2017- 2024, Forecast 2024-2043. Market, Financial, Competitive, Market Segmentation, Industry, Critical Parameters, Marketing Costs, Markets, Decision Makers, Performance, Product Launch.
WORLD & NATIONAL REPORT MARKET DATABASE & SPREADSHEETS: 1332 World Database tables & Spreadsheets covering business scenarios. 1435 World Database tables & Spreadsheets covering Markets, Market Forecast, Financial Forecast, Financial Margins, Historic Financial, Historic Costs, Industry Norms for each country. 3816 National Database tables & Spreadsheets covering business scenarios.
FINANCIAL SPREADSHEETS & DATABASES: 188 Balance Sheet, Financial Margins & Ratios for each of 103 Business Scenarios - by Country by Year - Forecast 2017- 2024, Forecast 2024-2043.
INDUSTRY SPREADSHEETS & DATABASES: 820 Database tables & Spreadsheets covering Historic Industry Balance Sheet Data, Forecast Industry Financial Data, Industry Profiles & Norms - by Country by Year - Forecast 2017- 2024, Forecast 2024-2043.
NATIONAL DATA - by Country by Year.
The report is produced on a DVD containing the entire report web and databases, and it is also supplied online as a zipped file. Readers can access & reproduce the information for their own documents or reports. Tables & databases as Access & Excel formats on the DVD to enable readers to produce their own spreadsheet calculations and modelling.
10 Products covered for over 200 Countries: 2152 pages, 9743 spreadsheets, 9734 database tables, 557 diagrams & maps.
This database is updated monthly. 12 months Full After-Sales Services & Updates available from the publishers.
This database is also available as 9 Regional Reports: Canada and the USA, Central America (31 countries), South America (13 countries), Europe (45 countries), Eurasia (4 countries), Middle East (19 Countries), Africa (54 countries), Asia (48 countries), and Oceania (20 countries).
This database is also available as reports for individual countries, and also reports on Cities and Towns within particular countries. SHOW LESS READ MORE >
The Market for Marine Machinery, Equipment & Supplies Wholesale Lines in each country by Products & Services.
The Marine Machinery, Equipment & Supplies Wholesale Lines World Report covers:
Historic 2009- 2015 - by each year.
Forecasts 2016- 2024 - by each year.
Report Specifications
World Market Historic: US$ Million
World Market Forecast: US$ Million
Canada & USA Market Historic: US$ Million
Canada & USA Market Forecast: US$ Million
Central America Market Historic: US$ Million
Central America Market Forecast: US$ Million
South America Market Historic: US$ Million
South America Market Forecast: US$ Million
Europe Market Historic: US$ Million
Europe Market Forecast: US$ Million
Eurasia Market Historic: US$ Million
Eurasia Market Forecast: US$ Million
Middle East Market Historic: US$ Million
Middle East Market Forecast: US$ Million
Africa Market Historic: US$ Million
Africa Market Forecast: US$ Million
Asia Market Historic: US$ Million
Asia Market Forecast: US$ Million
Oceania Market Historic: US$ Million
Oceania Market Forecast: US$ Million
Algeria Market Historic: US$ Million
Algeria Market Forecast: US$ Million
Algeria Financials Historic
Algeria Financials Forecast
Algeria Industry Norms
Argentina Market Historic: US$ Million
Argentina Market Forecast: US$ Million
Argentina Financials Historic
Argentina Financials Forecast
Argentina Industry Norms
Australia Market Historic: US$ Million
Australia Market Forecast: US$ Million
Australia Financials Historic
Australia Financials Forecast
Australia Industry Norms
Austria Market Historic: US$ Million
Austria Market Forecast: US$ Million
Austria Financials Historic
Austria Financials Forecast
Austria Industry Norms
Azerbaijan Market Historic: US$ Million
Azerbaijan Market Forecast: US$ Million
Azerbaijan Financials Historic
Azerbaijan Financials Forecast
Azerbaijan Industry Norms
Bahrain Market Historic: US$ Million
Bahrain Market Forecast: US$ Million
Bahrain Financials Historic
Bahrain Financials Forecast
Bahrain Industry Norms
Bangladesh Market Historic: US$ Million
Bangladesh Market Forecast: US$ Million
Bangladesh Financials Historic
Bangladesh Financials Forecast
Bangladesh Industry Norms
Belarus Market Historic: US$ Million
Belarus Market Forecast: US$ Million
Belarus Financials Historic
Belarus Financials Forecast
Belarus Industry Norms
Belgium Market Historic: US$ Million
Belgium Market Forecast: US$ Million
Belgium Financials Historic
Belgium Financials Forecast
Belgium Industry Norms
Bolivia Market Historic: US$ Million
Bolivia Market Forecast: US$ Million
Bolivia Financials Historic
Bolivia Financials Forecast
Bolivia Industry Norms
Bosnia and Herzegovina Market Historic: US$ Million
Bosnia and Herzegovina Market Forecast: US$ Million
Bosnia and Herzegovina Financials Historic
Bosnia and Herzegovina Financials Forecast
Bosnia and Herzegovina Industry Norms
Botswana Market Historic: US$ Million
Botswana Market Forecast: US$ Million
Botswana Financials Historic
Botswana Financials Forecast
Botswana Industry Norms
Brazil Market Historic: US$ Million
Brazil Market Forecast: US$ Million
Brazil Financials Historic
Brazil Financials Forecast
Brazil Industry Norms
Bulgaria Market Historic: US$ Million
Bulgaria Market Forecast: US$ Million
Bulgaria Financials Historic
Bulgaria Financials Forecast
Bulgaria Industry Norms
Cambodia Market Historic: US$ Million
Cambodia Market Forecast: US$ Million
Cambodia Financials Historic
Cambodia Financials Forecast
Cambodia Industry Norms
Canada Market Historic: US$ Million
Canada Market Forecast: US$ Million
Canada Financials Historic
Canada Financials Forecast
Canada Industry Norms
Chile Market Historic: US$ Million
Chile Market Forecast: US$ Million
Chile Financials Historic
Chile Financials Forecast
Chile Industry Norms
China Market Historic: US$ Million
China Market Forecast: US$ Million
China Financials Historic
China Financials Forecast
China Industry Norms
Colombia Market Historic: US$ Million
Colombia Market Forecast: US$ Million
Colombia Financials Historic
Colombia Financials Forecast
Colombia Industry Norms
Costa Rica Market Historic: US$ Million
Costa Rica Market Forecast: US$ Million
Costa Rica Financials Historic
Costa Rica Financials Forecast
Costa Rica Industry Norms
Croatia Market Historic: US$ Million
Croatia Market Forecast: US$ Million
Croatia Financials Historic
Croatia Financials Forecast
Croatia Industry Norms
Cuba Market Historic: US$ Million
Cuba Market Forecast: US$ Million
Cuba Financials Historic
Cuba Financials Forecast
Cuba Industry Norms
Cyprus Market Historic: US$ Million
Cyprus Market Forecast: US$ Million
Cyprus Financials Historic
Cyprus Financials Forecast
Cyprus Industry Norms
Czech Republic Market Historic: US$ Million
Czech Republic Market Forecast: US$ Million
Czech Republic Financials Historic
Czech Republic Financials Forecast
Czech Republic Industry Norms
Denmark Market Historic: US$ Million
Denmark Market Forecast: US$ Million
Denmark Financials Historic
Denmark Financials Forecast
Denmark Industry Norms
Ecuador Market Historic: US$ Million
Ecuador Market Forecast: US$ Million
Ecuador Financials Historic
Ecuador Financials Forecast
Ecuador Industry Norms
Egypt Market Historic: US$ Million
Egypt Market Forecast: US$ Million
Egypt Financials Historic
Egypt Financials Forecast
Egypt Industry Norms
El Salvador Market Historic: US$ Million
El Salvador Market Forecast: US$ Million
El Salvador Financials Historic
El Salvador Financials Forecast
El Salvador Industry Norms
Estonia Market Historic: US$ Million
Estonia Market Forecast: US$ Million
Estonia Financials Historic
Estonia Financials Forecast
Estonia Industry Norms
Finland Market Historic: US$ Million
Finland Market Forecast: US$ Million
Finland Financials Historic
Finland Financials Forecast
Finland Industry Norms
France Market Historic: US$ Million
France Market Forecast: US$ Million
France Financials Historic
France Financials Forecast
France Industry Norms
French Guiana Market Historic: US$ Million
French Guiana Market Forecast: US$ Million
French Guiana Financials Historic
French Guiana Financials Forecast
French Guiana Industry Norms
Georgia Market Historic: US$ Million
Georgia Market Forecast: US$ Million
Georgia Financials Historic
Georgia Financials Forecast
Georgia Industry Norms
Germany Market Historic: US$ Million
Germany Market Forecast: US$ Million
Germany Financials Historic
Germany Financials Forecast
Germany Industry Norms
Ghana Market Historic: US$ Million
Ghana Market Forecast: US$ Million
Ghana Financials Historic
Ghana Financials Forecast
Ghana Industry Norms
Greece Market Historic: US$ Million
Greece Market Forecast: US$ Million
Greece Financials Historic
Greece Financials Forecast
Greece Industry Norms
Guyana Market Historic: US$ Million
Guyana Market Forecast: US$ Million
Guyana Financials Historic
Guyana Financials Forecast
Guyana Industry Norms
Honduras Market Historic: US$ Million
Honduras Market Forecast: US$ Million
Honduras Financials Historic
Honduras Financials Forecast
Honduras Industry Norms
Hong Kong Market Historic: US$ Million
Hong Kong Market Forecast: US$ Million
Hong Kong Financials Historic
Hong Kong Financials Forecast
Hong Kong Industry Norms
Hungary Market Historic: US$ Million
Hungary Market Forecast: US$ Million
Hungary Financials Historic
Hungary Financials Forecast
Hungary Industry Norms
Iceland Market Historic: US$ Million
Iceland Market Forecast: US$ Million
Iceland Financials Historic
Iceland Financials Forecast
Iceland Industry Norms
India Market Historic: US$ Million
India Market Forecast: US$ Million
India Financials Historic
India Financials Forecast
India Industry Norms
Indonesia Market Historic: US$ Million
Indonesia Market Forecast: US$ Million
Indonesia Financials Historic
Indonesia Financials Forecast
Indonesia Industry Norms
Iran Market Historic: US$ Million
Iran Market Forecast: US$ Million
Iran Financials Historic
Iran Financials Forecast
Iran Industry Norms
Ireland Market Historic: US$ Million
Ireland Market Forecast: US$ Million
Ireland Financials Historic
Ireland Financials Forecast
Ireland Industry Norms
Israel Market Historic: US$ Million
Israel Market Forecast: US$ Million
Israel Financials Historic
Israel Financials Forecast
Israel Industry Norms
Italy Market Historic: US$ Million
Italy Market Forecast: US$ Million
Italy Financials Historic
Italy Financials Forecast
Italy Industry Norms
Jamaica Market Historic: US$ Million
Jamaica Market Forecast: US$ Million
Jamaica Financials Historic
Jamaica Financials Forecast
Jamaica Industry Norms
Japan Market Historic: US$ Million
Japan Market Forecast: US$ Million
Japan Financials Historic
Japan Financials Forecast
Japan Industry Norms
Kazakhstan Market Historic: US$ Million
Kazakhstan Market Forecast: US$ Million
Kazakhstan Financials Historic
Kazakhstan Financials Forecast
Kazakhstan Industry Norms
Kenya Market Historic: US$ Million
Kenya Market Forecast: US$ Million
Kenya Financials Historic
Kenya Financials Forecast
Kenya Industry Norms
Kuwait Market Historic: US$ Million
Kuwait Market Forecast: US$ Million
Kuwait Financials Historic
Kuwait Financials Forecast
Kuwait Industry Norms
Kyrgyzstan Market Historic: US$ Million
Kyrgyzstan Market Forecast: US$ Million
Kyrgyzstan Financials Historic
Kyrgyzstan Financials Forecast
Kyrgyzstan Industry Norms
Laos Market Historic: US$ Million
Laos Market Forecast: US$ Million
Laos Financials Historic
Laos Financials Forecast
Laos Industry Norms
Latvia Market Historic: US$ Million
Latvia Market Forecast: US$ Million
Latvia Financials Historic
Latvia Financials Forecast
Latvia Industry Norms
Lebanon Market Historic: US$ Million
Lebanon Market Forecast: US$ Million
Lebanon Financials Historic
Lebanon Financials Forecast
Lebanon Industry Norms
Lithuania Market Historic: US$ Million
Lithuania Market Forecast: US$ Million
Lithuania Financials Historic
Lithuania Financials Forecast
Lithuania Industry Norms
Luxembourg Market Historic: US$ Million
Luxembourg Market Forecast: US$ Million
Luxembourg Financials Historic
Luxembourg Financials Forecast
Luxembourg Industry Norms
Malawi Market Historic: US$ Million
Malawi Market Forecast: US$ Million
Malawi Financials Historic
Malawi Financials Forecast
Malawi Industry Norms
Malaysia Market Historic: US$ Million
Malaysia Market Forecast: US$ Million
Malaysia Financials Historic
Malaysia Financials Forecast
Malaysia Industry Norms
Mexico Market Historic: US$ Million
Mexico Market Forecast: US$ Million
Mexico Financials Historic
Mexico Financials Forecast
Mexico Industry Norms
Morocco Market Historic: US$ Million
Morocco Market Forecast: US$ Million
Morocco Financials Historic
Morocco Financials Forecast
Morocco Industry Norms
Netherlands Market Historic: US$ Million
Netherlands Market Forecast: US$ Million
Netherlands Financials Historic
Netherlands Financials Forecast
Netherlands Industry Norms
New Zealand Market Historic: US$ Million
New Zealand Market Forecast: US$ Million
New Zealand Financials Historic
New Zealand Financials Forecast
New Zealand Industry Norms
Nicaragua Market Historic: US$ Million
Nicaragua Market Forecast: US$ Million
Nicaragua Financials Historic
Nicaragua Financials Forecast
Nicaragua Industry Norms
Nigeria Market Historic: US$ Million
Nigeria Market Forecast: US$ Million
Nigeria Financials Historic
Nigeria Financials Forecast
Nigeria Industry Norms
Norway Market Historic: US$ Million
Norway Market Forecast: US$ Million
Norway Financials Historic
Norway Financials Forecast
Norway Industry Norms
Pakistan Market Historic: US$ Million
Pakistan Market Forecast: US$ Million
Pakistan Financials Historic
Pakistan Financials Forecast
Pakistan Industry Norms
Panama Market Historic: US$ Million
Panama Market Forecast: US$ Million
Panama Financials Historic
Panama Financials Forecast
Panama Industry Norms
Paraguay Market Historic: US$ Million
Paraguay Market Forecast: US$ Million
Paraguay Financials Historic
Paraguay Financials Forecast
Paraguay Industry Norms
Peru Market Historic: US$ Million
Peru Market Forecast: US$ Million
Peru Financials Historic
Peru Financials Forecast
Peru Industry Norms
Philippines Market Historic: US$ Million
Philippines Market Forecast: US$ Million
Philippines Financials Historic
Philippines Financials Forecast
Philippines Industry Norms
Poland Market Historic: US$ Million
Poland Market Forecast: US$ Million
Poland Financials Historic
Poland Financials Forecast
Poland Industry Norms
Portugal Market Historic: US$ Million
Portugal Market Forecast: US$ Million
Portugal Financials Historic
Portugal Financials Forecast
Portugal Industry Norms
Romania Market Historic: US$ Million
Romania Market Forecast: US$ Million
Romania Financials Historic
Romania Financials Forecast
Romania Industry Norms
Russia Market Historic: US$ Million
Russia Market Forecast: US$ Million
Russia Financials Historic
Russia Financials Forecast
Russia Industry Norms
Saudi Arabia Market Historic: US$ Million
Saudi Arabia Market Forecast: US$ Million
Saudi Arabia Financials Historic
Saudi Arabia Financials Forecast
Saudi Arabia Industry Norms
Serbia and Montenegro Market Historic: US$ Million
Serbia and Montenegro Market Forecast: US$ Million
Serbia and Montenegro Financials Historic
Serbia and Montenegro Financials Forecast
Serbia and Montenegro Industry Norms
Singapore Market Historic: US$ Million
Singapore Market Forecast: US$ Million
Singapore Financials Historic
Singapore Financials Forecast
Singapore Industry Norms
Slovakia Market Historic: US$ Million
Slovakia Market Forecast: US$ Million
Slovakia Financials Historic
Slovakia Financials Forecast
Slovakia Industry Norms
Slovenia Market Historic: US$ Million
Slovenia Market Forecast: US$ Million
Slovenia Financials Historic
Slovenia Financials Forecast
Slovenia Industry Norms
South Africa Market Historic: US$ Million
South Africa Market Forecast: US$ Million
South Africa Financials Historic
South Africa Financials Forecast
South Africa Industry Norms
South Korea Market Historic: US$ Million
South Korea Market Forecast: US$ Million
South Korea Financials Historic
South Korea Financials Forecast
South Korea Industry Norms
Spain Market Historic: US$ Million
Spain Market Forecast: US$ Million
Spain Financials Historic
Spain Financials Forecast
Spain Industry Norms
Sri Lanka Market Historic: US$ Million
Sri Lanka Market Forecast: US$ Million
Sri Lanka Financials Historic
Sri Lanka Financials Forecast
Sri Lanka Industry Norms
Suriname Market Historic: US$ Million
Suriname Market Forecast: US$ Million
Suriname Financials Historic
Suriname Financials Forecast
Suriname Industry Norms
Sweden Market Historic: US$ Million
Sweden Market Forecast: US$ Million
Sweden Financials Historic
Sweden Financials Forecast
Sweden Industry Norms
Switzerland Market Historic: US$ Million
Switzerland Market Forecast: US$ Million
Switzerland Financials Historic
Switzerland Financials Forecast
Switzerland Industry Norms
Taiwan Market Historic: US$ Million
Taiwan Market Forecast: US$ Million
Taiwan Financials Historic
Taiwan Financials Forecast
Taiwan Industry Norms
Tanzania Market Historic: US$ Million
Tanzania Market Forecast: US$ Million
Tanzania Financials Historic
Tanzania Financials Forecast
Tanzania Industry Norms
Thailand Market Historic: US$ Million
Thailand Market Forecast: US$ Million
Thailand Financials Historic
Thailand Financials Forecast
Thailand Industry Norms
Tunisia Market Historic: US$ Million
Tunisia Market Forecast: US$ Million
Tunisia Financials Historic
Tunisia Financials Forecast
Tunisia Industry Norms
Turkey Market Historic: US$ Million
Turkey Market Forecast: US$ Million
Turkey Financials Historic
Turkey Financials Forecast
Turkey Industry Norms
Uganda Market Historic: US$ Million
Uganda Market Forecast: US$ Million
Uganda Financials Historic
Uganda Financials Forecast
Uganda Industry Norms
Ukraine Market Historic: US$ Million
Ukraine Market Forecast: US$ Million
Ukraine Financials Historic
Ukraine Financials Forecast
Ukraine Industry Norms
United Arab Emirates Market Historic: US$ Million
United Arab Emirates Market Forecast: US$ Million
United Arab Emirates Financials Historic
United Arab Emirates Financials Forecast
United Arab Emirates Industry Norms
United Kingdom Market Historic: US$ Million
United Kingdom Market Forecast: US$ Million
United Kingdom Financials Historic
United Kingdom Financials Forecast
United Kingdom Industry Norms
United States Market Historic: US$ Million
United States Market Forecast: US$ Million
United States Financials Historic
United States Financials Forecast
United States Industry Norms
Uruguay Market Historic: US$ Million
Uruguay Market Forecast: US$ Million
Uruguay Financials Historic
Uruguay Financials Forecast
Uruguay Industry Norms
Uzbekistan Market Historic: US$ Million
Uzbekistan Market Forecast: US$ Million
Uzbekistan Financials Historic
Uzbekistan Financials Forecast
Uzbekistan Industry Norms
Venezuela Market Historic: US$ Million
Venezuela Market Forecast: US$ Million
Venezuela Financials Historic
Venezuela Financials Forecast
Venezuela Industry Norms
Vietnam Market Historic: US$ Million
Vietnam Market Forecast: US$ Million
Vietnam Financials Historic
Vietnam Financials Forecast
Vietnam Industry Norms
Zambia Market Historic: US$ Million
Zambia Market Forecast: US$ Million
Zambia Financials Historic
Zambia Financials Forecast
Zambia Industry Norms
Market Notes & Definitions
Financial Notes & Definitions
Industry Norms Definitions
To upgrade to the full Database Edition you can use the coupon to order the upgrade edition you need at a reduced cost.
Database Editions
Editions available
Markets & Products
Products covered
Geographic Coverage
Financial data
General Contents
Database Edition Market Research Contents
Databases & Structures
Proprietary Software package compatibility
Resource Web
The Entry Level product
Real Time Support
Research & Survey Methodology Analysis
Appendix 1: Regional Report country coverage
Appendix 2: About the After-Sales Service
How to order After-Sales Services
Modular Research
1. Market Research
2. Distribution Channels & End Users Data
3. Survey Data
4. Corporate Data
5. Additional Data
Database Products supported by the After-Sales Service
The Marine Machinery, Equipment & Supplies Wholesale Lines Global Report is now available.
This report is a comprehensive and far reaching report on Marine Machinery, Equipment & Supplies Wholesale Lines and it provides vital data to business, financial, commercial and government analysts.
The Marine Machinery, Equipment & Supplies Wholesale Lines Global Report provides data on the net market for the Products and Services covered in each of 100 countries. The Products and Services covered (Marine machinery, equip & supp merchant wholesalers Lines) are classified by the 5-Digit United States Commerce Department Major Product Codes and each Product and Services is then further defined and analyzed by each 6 to 10-Digit United States Commerce Department Product Codes.
The Marine Machinery, Equipment & Supplies Wholesale Lines World Report gives Market Consumption / Products / Services for 100 countries by 6 to 10-Digit NAICS Product Codes by Time series: 2009- 2016 and Forecasts 2017- 2024.
Products covered include:
1. Marine machinery, equipment and supplies merchant wholesalers Product Lines
2. Other mechanical power transmission supplies
3. New ships and boats, excluding pleasure boats
4. New marine propulsion machinery and equipment
5. New marine supplies
6. Used marine machinery, equipment, and supplies
7. Labor charges for repair work
8. Parts installed in repair work
9. Other service receipts and labor charges
- Algeria
- Argentina
- Armenia
- Australia
- Austria
- Azerbaijan
- Bahrain
- Bangladesh
- Belarus
- Belgium
- Bolivia
- Bosnia and Herzegovina
- Botswana
- Brazil
- Bulgaria
- Cambodia
- Canada
- Chile
- Colombia
- Costa Rica
- Croatia
- Cuba
- Cyprus
- Czech Republic
- Denmark
- Ecuador
- Egypt
- El Salvador
- Estonia
- Finland
- France
- French Guiana
- Georgia
- Germany
- Ghana
- Greece
- Guyana
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Kazakhstan
- Kenya
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lithuania
- Luxembourg
- Malawi
- Malaysia
- Mexico
- Morocco
- New Zealand
- Nicaragua
- Nigeria
- Norway
- Pakistan
- Panama
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Serbia and Montenegro
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Suriname
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- The Netherlands
- Tunisia
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Uruguay
- Uzbekistan
- Venezuela
- Vietnam
- Zambia
Does this report contain information on any of the following topics?
-State of the marine filler and fiberglass repair market
-State of and opportunities in marine products retailing
-Volume of sales for marine fillers in the US
-Key competitors
-Details of how the marine retail environment works
-Volumes of filler sales/fiberglass repair kit sales
-Boat owner demographics
-boat repair industry information
|Unfortunately the report does not contain information on the mentioned topics.


text:
Browse by Category
Micro Generation (40)
Search results in category Micro Generation
No results were found for the search criteria you requested. Please try your search again.
ERROR: http://www.mygreendirectory.info/listing/results.php Query: INSERT INTO Report_Banners (banner_id, report_type, report_amount, date,module,category) VALUES (543, 2, 1, NOW(),'listing',130) Errno: 144 Error: Table './mygreen_domain_1/Report_Banners' is marked as crashed and last (automatic?) repair failed _SERVER data REMOTE_ADDR : 22.214.171.124 REMOTE_PORT : 55668 SCRIPT_FILENAME : /home/mygreendir/public_html/listing/results.php REQUEST_METHOD : GET QUERY_STRING : letter=c&category_id=130 REQUEST_URI : /listing/results.php?letter=c&category_id=130
Advertisers Do you want to advertise with us?


text:
For Michael Kohn, the bruise on his butt — courtesy of a line drive off the bat of Miguel Cabrera — is a badge of honor.
Career MLB stats for former College of Charleston pitcher Michael Kohn:
Year Team W-L ERA Saves IP
2010 Angels 2-0 2.11 1 21.1
2011 Angels 0-1 7.30 1 12.1
2013 Angels 1-0 2.35 0 30.2
Totals 3-1 3.29 2 63
Cabrera, the 2012 Triple Crown winner, smacked a shot off Kohn's backside during a game last month. Kohn scrambled to retrieve the ball and threw Cabrera out at first base.
"I'd take 10 more just like it, if I could get him out every time," said Kohn, who had given up a two-run home run and a walk the first two times he faced the Detroit Tigers' star.
The next night, Kohn (pronounced "Kahn") faced Cabrera with two on and two out in the eighth inning of a tie game. This time, he struck out Cabrera with a 94-mph fastball, and the Angels went on to win the game, 3-1, in extra innings.
"It felt a whole lot better than getting hit in the (rear end)," Kohn texted friends and family after the game.
Kohn's quick learning curve against Cabrera mirrors his fast rise from a benched first baseman at College of Charleston to a fixture in the Los Angeles Angels' bullpen. After throwing all of 13 innings as a college pitcher, Kohn is 1-0 with a 2.35 earned-run average in 33 appearances for the Angels this season, and was included on the players' ballot for the American League All-Star roster.
"It was cool for me just to see my name on there, next to Cabrera and Mariano Rivera and guys like that," Kohn said recently. "I voted for (Lowcountry products) Brett Gardner and Matt Wieters, so it was cool to be able to vote for two other Charleston guys."
The 6-2, 200-pound right-hander has a unique backstory. He grew up in one of Camden's foremost families — his grandfather was a three-star admiral in the Navy, and on his mom's side he's related to former state Rep. Bob Sheheen and state Rep. Vincent Sheheen, the Democratic candidate for S.C. governor in 2010.
Kohn played at USC Upstate before transferring to College of Charleston, where in 2007 he hit .312 with nine homers and 42 runs batted in. But after losing his starting job halfway through the season, he went to Scott Foxhall, then the Cougars' pitching coach, with a wild idea.
"It was just a joke between me and Foxhall," Kohn recalls. "I'd say, 'Let me try to pitch,' and he'd shoo me away. But I ended up getting on the mound and throwing eight to 10 pitches."
When Kohn lit up the radar gun at 96 mph, the Cougars had a new pitcher.
"I didn't know how hard I could throw," Kohn said. "I knew I had a pretty good arm from throwing in the outfield. I was hoping I could at least throw 90. I do remember my high school coach saying, 'Don't be surprised if they try to convert you to a pitcher.' "
But all the weightlifting Kohn had done as a hitter worked against him as a pitcher. After a shoulder injury during his senior season, renowned surgeon Dr. James Andrews told him he was too big in the upper body and had to lose weight.
"All that good beach muscle had to come off," said Kohn, who was able to come back and pitch 13 innings as a senior, going 0-1 with a 2.08 ERA and four saves in 14 appearances.
That was enough for the Angels to make Kohn a 13th-round pick in the 2008 MLB draft. The club had gotten a heads-up on Kohn from College of Charleston softball player Christal Kotchman, daughter of former Angels scout Tim Kotchman and sister of Marlins first baseman Casey Kotchman.
By 2010, after just one full season in Class A, Kohn had made his MLB debut with the Angels, a meteoric rise for a pitcher with just 13 college innings behind him.
"Coming out of college, so many guys have so many innings under their belt," he said. "I didn't get abused at all in college, so I had a fresh arm coming up. That was a huge upside for me."
Of course, Kohn also had a lot to learn about getting hitters out.
"Every pitcher out there was 10 or 12 years ahead of me in experience," he said. "I had to learn very quickly. But I think being a hitter helped me. I knew what hitters liked in certain counts, and that helped me a lot early on."
After he struggled in 2011, Kohn underwent Tommy John surgery in April 2012 and missed last season. This year, he's earned a role as a late-inning reliever in the Angels' bullpen, allowing opponents to hit just .150, with 33 strikeouts in 302/3 innings.
"There's been noticeable improvement in his stuff, in particular his velocity," Angels manager Mike Scioscia told reporters earlier this season. "He's able to spin his slider now that he's healthy. He's done a great job in whatever situation we put him in."
Kohn also struck out Tigers All-Star Torii Hunter that night in Detroit. Hunter had served as a mentor for Kohn with the Angels, and when Hunter was traded to the Tigers, he gave Kohn his locker.
"Torii was a big part of my career," Kohn said. "I learned a lot from him, and you have to be willing to learn in this game. You have to be a sponge and soak up as much as you can."
With the Angels, Kohn can pick the brains of hitters Mike Trout, Albert Pujols and Josh Hamilton, and veteran pitchers Jered Weaver and Scott Downs.
"They are all awesome guys," he said. "They are normal guys, they just happen to be in the spotlight more. Trout is one of my best friends on the team. We like the same things, like golf and the outdoors, hunting in the offseason. I can't wait to get him down to Charleston for some deer hunting."
Kohn said he grew up dreaming of playing shortstop and batting third for the Braves. He's living a different kind of dream — pitching for the Angels, living in Newport Beach, Calif., during the season, in Charleston in the offseason and hanging with girlfriend Chelsea Meissner of "Survivor" fame. They met in a bar on Sullivan's Island.
"I wouldn't trade it for anything in the world," he said. "Playing baseball was my goal since I was a little kid. It's a little different scenario than I dreamed of, but it's awesome. I love it."


text:
Thunder may be mixed in holiday's fireworks; emergency workers get ready for crowds, heat
July 4, 2013
Mother Nature may add her own booms to this afternoon and tonight's musical performances and a display of fireworks downtown at 9:30 p.m....
for once im not going to post negative. thank you city of williamsport for taking precautions and for putting on this fabulous day for this many years. it seems like its been more than 18 years though. i remember going to this before i was out of high school, and that was well over 20 years ago.
0 Agrees | 0 Disagrees | Report Abuse »
Showing 1 of 1 comments
Post a Comment
You must first login before you can comment.